Albert Labs International Corp. (ABRT.CN)
Stock analysis · CNQ · Healthcare · Biotechnology
Market Cap
N/A
PE (TTM)
N/A
EPS (TTM)
N/A
Dividend Yield
N/A
Beta
2.13
Day Range
N/A
52-wk Range
N/A
Avg Volume
N/A
Volume
N/A
Albert Labs International Corp. (ABRT.CN) is a publicly traded company in the Healthcare sector. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.
Get full analysis → Short-Term Analysis →Proprietary Signals
About Albert Labs International Corp.
Albert Labs International Corp. is a pharmaceutical research and development company dedicated to addressing urgent and underserved patient needs, particularly in critical mental health. The firm specializes in creating psilocybin-assisted therapies aimed at improving conditions such as anxiety, depression, and the psychological distress linked to cancer. This enterprise operates out of Burnaby, Canada.
Peers
Recent News
- No recent news available.
Related
Browse more tickers: sitemap